We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Critics are using the FTC’s proposed study of authorized generics to raise concerns that the practice has a negative impact on prices, availability and competition among generics.